Recursion Pharmaceuticals
RXRX
#3776
Rank
A$4.27 B
Marketcap
$10.94
Share price
5.36%
Change (1 day)
-31.14%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2024 (TTM): -A$0.57 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are A$64.6 Million. In 2023 the company made an earning of -A$0.53 Billion a decrease over its 2022 earnings that were of -A$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.57 Billion7.42%
2023 -A$0.53 Billion38.68%
2022 -A$0.39 Billion30.46%
2021 -A$0.3 Billion114.28%
2020 -A$0.14 Billion